Vanguard's 5.08% passive stake is consistent with index fund positioning and does not signal activist intent. Monitor for any future 13D conversion or additional accumulation above 10%, which would be more notable.
Price Chart
Executive Summary
Vanguard Capital Management LLC filed a Schedule 13G disclosing a 5.08% passive stake in Dianthus Therapeutics. This is a new filing (not an amendment) by a major index fund manager, indicating routine portfolio accumulation. The stake is passive with no intent to influence control.
Key Financial Metrics
Key Facts
- Vanguard Capital Management LLC filed a new Schedule 13G for Dianthus Therapeutics on 2026-10-30.
- Vanguard beneficially owns 2,846,786 shares of common stock, representing 5.08% of shares outstanding.
- The filing certifies passive intent under Rule 13d-1(b) with no purpose of changing or influencing control.
- This is Vanguard's first SC 13G filing for DNTH; no prior filing by this entity appears in the cross-filing context.
- Vanguard's stake is held across multiple affiliates including Vanguard Asset Management Limited, Vanguard Fiduciary Trust Company, Vanguard Global Advisers, LLC, and Vanguard Investments Australia Ltd.
Financial Impact
2,846,786 shares valued at approximately $145M based on $4.6B market cap and 5.08% stake
Risk Factors
- No material risk identified; passive 5%+ stakes by index managers are routine and non-directional.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G Filing (Primary) | 0002100119-26-001565 |
| Document: 0002100119-26-001565-index.html | 0002100119-26-001565 |
| Document: 0002100119-26-001565.txt | 0002100119-26-001565 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 30, 2026 2d ago | Institutional Cluster | $81.21 | awaiting T+1 | awaiting T+1 | $82.38 (+1.44%) |
Oct 30, 2026 2d ago | SC 13G | $82.15 | awaiting T+1 | awaiting T+1 | $82.38 (+0.28%) |
Oct 12, 2026 20d ago | Institutional Cluster | $81.57 $77.58 | ▼ −4.89% | ▼ −4.88% | $82.38 (+0.99%) |
Aug 11, 2026 11w ago | Insider Cluster | $112.41 $109.60 | ▼ −2.50% | ▼ −3.20% | $82.38 (−26.71%) |
Aug 11, 2026 11w ago | Insider Cluster | $112.41 $109.60 | ▼ −2.50% | ▼ −3.20% | $82.38 (−26.71%) |
Aug 11, 2026 11w ago | Insider Cluster | $112.41 $109.60 | ▼ −2.50% | ▼ −3.20% | $82.38 (−26.71%) |
Aug 11, 2026 11w ago | Insider Cluster | $112.41 $109.60 | ▲ +2.50% | ▲ +3.20% | $82.38 (+26.71%) |
Aug 10, 2026 11w ago | 144 | $108.49 $112.41 | ▲ +3.61% | ▲ +3.36% | $82.38 (−24.07%) |
Jun 29, 2026 17w ago | Press Release | $95.68 $97.48 | ▲ +1.88% | ▲ +1.10% | $82.38 (−13.90%) |
Jun 12, 2026 20w ago | 8-K | $82.07 $82.51 | ▲ +0.54% | ▼ −1.23% | $82.38 (+0.38%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers